Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
VARUBI (ROLAPITANT HYDROCHLORIDE) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
VARUBI
NDA
Get alerts
ROLAPITANT HYDROCHLORIDE | N208399 | TERSERA THERAPEUTICS LLC
1 strength
6 unique patents
0 unique exclusivities
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
DMF
Approvals
Label
Products
Patent Timeline
6 unique patents by expiration date
Expiring < 1yr (3)
Active (3)
Today
2027
2028
2029
2030
2031
2032
Today
7049320
Aug. 19, 2028
7981905
Apr. 4, 2027
8178550
Apr. 4, 2027
8404702
Apr. 4, 2027
8470842
Jan. 18, 2029
9101615
Jul. 14, 2032
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 166.5MG BASE/92.5ML (EQ 1.8MG BASE/ML)
RLD
6 patents
0 exclusivities
▴
EMULSION;INTRAVENOUS | Approved: Oct 25, 2017
Patents (6)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
7049320
Aug 19, 2028
—
Yes
Yes
U-1741
PREVENTION OF DELAYED NAUSEA AND VOMITING ASSOCIATED WITH EMETOGENIC CANCER CHEMOTHERAPY
—
7981905
Apr 4, 2027
—
—
—
U-1741
PREVENTION OF DELAYED NAUSEA AND VOMITING ASSOCIATED WITH EMETOGENIC CANCER CHEMOTHERAPY
—
8178550
Apr 4, 2027
—
Yes
Yes
—
—
8404702
Apr 4, 2027
—
—
—
U-1741
PREVENTION OF DELAYED NAUSEA AND VOMITING ASSOCIATED WITH EMETOGENIC CANCER CHEMOTHERAPY
—
8470842
Jan 18, 2029
—
—
—
U-1741
PREVENTION OF DELAYED NAUSEA AND VOMITING ASSOCIATED WITH EMETOGENIC CANCER CHEMOTHERAPY
—
9101615
Jul 14, 2032
—
—
—
U-1741
PREVENTION OF DELAYED NAUSEA AND VOMITING ASSOCIATED WITH EMETOGENIC CANCER CHEMOTHERAPY
—